Jazz Pharmaceuticals plc Tax Withholding Paid on Stock Awards
Jazz Pharmaceuticals plc (JAZZ) reported Tax Withholding Paid on Stock Awards of $113.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-03
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $9.50M, a 331.82% increase year-over-year.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $103.60M, a 54.17% increase year-over-year.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $2.00M, a 50.16% decline year-over-year.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $3.82M, a 138.26% increase year-over-year.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for fiscal 2025 was $75.22M, a 30.24% increase from fiscal 2024.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for fiscal 2024 was $57.75M, a 13.35% increase from fiscal 2023.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for fiscal 2023 was $50.95M, a 12.12% increase from fiscal 2022.
- Jazz Pharmaceuticals plc payment, tax withholding, share-based payment arrangement for fiscal 2022 was $45.44M, a 27.64% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $113.10M 10-Q · filed 2026-08-03 | $115.10M derived: sum of 3 quarters · filed 2026-08-03 | $118.92M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $103.60M 10-Q · filed 2026-05-05 | $105.60M derived: sum of 2 quarters · filed 2026-05-05 | $109.42M derived: sum of 3 quarters · filed 2026-05-05 | $111.62M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.82M derived: sum of 2 quarters · filed 2026-02-24 | $8.02M derived: sum of 3 quarters · filed 2026-08-03 | $75.22M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.02M derived: sum of 2 quarters · filed 2026-08-03 | $73.22M 10-Q · filed 2025-11-05 | $77.23M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $69.40M 10-Q · filed 2026-08-03 | $69.41M 10-Q · filed 2025-08-06 | $73.41M derived: sum of 3 quarters · filed 2026-08-03 | $75.01M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $67.20M 10-Q · filed 2026-05-05 | $67.16M 10-Q · filed 2025-05-07 | $71.20M derived: sum of 2 quarters · filed 2026-05-05 | $72.81M derived: sum of 3 quarters · filed 2026-05-05 | $75.66M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.61M derived: sum of 2 quarters · filed 2026-02-24 | $8.46M derived: sum of 3 quarters · filed 2026-02-24 | $57.75M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.45M derived: sum of 2 quarters · filed 2025-11-05 | $53.75M 10-Q · filed 2025-11-05 | $55.36M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $52.14M 10-Q · filed 2025-08-06 | $53.76M derived: sum of 3 quarters · filed 2026-02-24 | $55.64M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $49.30M 10-Q · filed 2025-05-07 | $50.91M derived: sum of 2 quarters · filed 2026-02-24 | $52.79M derived: sum of 3 quarters · filed 2026-02-24 | $56.98M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.50M derived: sum of 2 quarters · filed 2026-02-24 | $7.69M derived: sum of 3 quarters · filed 2026-02-24 | $50.95M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.07M derived: sum of 2 quarters · filed 2024-11-07 | $49.34M 10-Q · filed 2024-11-07 | $52.15M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $47.45M 10-Q · filed 2024-08-01 | $50.27M derived: sum of 3 quarters · filed 2025-02-26 | $52.83M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $43.27M 10-Q · filed 2024-05-02 | $46.08M derived: sum of 2 quarters · filed 2025-02-26 | $48.64M derived: sum of 3 quarters · filed 2025-02-26 | $54.93M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.38M derived: sum of 2 quarters · filed 2025-02-26 | $11.67M derived: sum of 3 quarters · filed 2025-02-26 | $45.44M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $8.86M derived: sum of 2 quarters · filed 2023-11-08 | $42.63M 10-Q · filed 2023-11-08 | $48.63M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $6.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $40.06M 10-Q · filed 2023-08-09 | $46.06M derived: sum of 3 quarters · filed 2024-02-28 | $48.49M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $33.78M 10-Q · filed 2023-05-10 | $39.77M derived: sum of 2 quarters · filed 2024-02-28 | $42.21M derived: sum of 3 quarters · filed 2024-02-28 | $45.59M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.43M derived: sum of 2 quarters · filed 2024-02-28 | $11.82M derived: sum of 3 quarters · filed 2024-02-28 | $35.60M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.82M derived: sum of 2 quarters · filed 2022-11-09 | $29.60M 10-Q · filed 2022-11-09 | $30.72M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $27.17M 10-Q · filed 2022-08-03 | $28.29M derived: sum of 3 quarters · filed 2023-03-01 | $29.39M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $23.78M 10-Q · filed 2022-05-04 | $24.90M derived: sum of 2 quarters · filed 2023-03-01 | $26.00M derived: sum of 3 quarters · filed 2023-03-01 | $27.11M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.21M derived: sum of 2 quarters · filed 2023-03-01 | $3.33M derived: sum of 3 quarters · filed 2023-03-01 | $16.88M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.21M derived: sum of 2 quarters · filed 2021-11-09 | $15.76M 10-Q · filed 2021-11-09 | $16.60M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $14.66M 10-Q · filed 2021-08-03 | $15.50M derived: sum of 3 quarters · filed 2022-03-01 | $16.59M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $13.55M 10-Q · filed 2021-05-04 | $14.39M derived: sum of 2 quarters · filed 2022-03-01 | $15.47M derived: sum of 3 quarters · filed 2022-03-01 | $16.48M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.93M derived: sum of 2 quarters · filed 2022-03-01 | $2.93M derived: sum of 3 quarters · filed 2022-03-01 | $16.74M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $2.09M derived: sum of 2 quarters · filed 2020-11-02 | $15.90M 10-Q · filed 2020-11-02 | $16.63M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $14.81M 10-Q · filed 2020-08-04 | $15.55M derived: sum of 3 quarters · filed 2021-02-23 | $16.71M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $13.81M 10-Q · filed 2020-05-05 | $14.54M derived: sum of 2 quarters · filed 2021-02-23 | $15.71M derived: sum of 3 quarters · filed 2021-02-23 | $17.14M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.90M derived: sum of 2 quarters · filed 2021-02-23 | $3.33M derived: sum of 3 quarters · filed 2021-02-23 | $17.93M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.60M derived: sum of 2 quarters · filed 2019-11-05 | $17.19M 10-Q · filed 2019-11-05 | $17.87M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $16.02M 10-Q · filed 2019-08-06 | $16.70M derived: sum of 3 quarters · filed 2020-02-25 | $18.29M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $14.59M 10-Q · filed 2019-05-07 | $15.27M derived: sum of 2 quarters · filed 2020-02-25 | $16.86M derived: sum of 3 quarters · filed 2020-02-25 | $18.75M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $680.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.27M derived: sum of 2 quarters · filed 2020-02-25 | $4.16M derived: sum of 3 quarters · filed 2020-02-25 | $18.59M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $3.48M derived: sum of 2 quarters · filed 2018-11-06 | $17.91M 10-Q · filed 2018-11-06 | $18.55M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $16.32M 10-Q · filed 2018-08-07 | $16.96M derived: sum of 3 quarters · filed 2019-02-26 | $23.28M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $14.43M 10-Q · filed 2018-05-08 | $15.07M derived: sum of 2 quarters · filed 2019-02-26 | $21.39M derived: sum of 3 quarters · filed 2019-02-26 | $23.19M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $6.96M derived: sum of 2 quarters · filed 2019-02-26 | $8.76M derived: sum of 3 quarters · filed 2019-02-26 | $21.23M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $8.12M derived: sum of 2 quarters · filed 2017-11-07 | $20.59M 10-Q · filed 2017-11-07 | $21.30M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $14.28M 10-Q · filed 2017-08-08 | $14.98M derived: sum of 3 quarters · filed 2018-02-27 | $23.70M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $12.48M 10-Q · filed 2017-05-09 | $13.18M derived: sum of 2 quarters · filed 2018-02-27 | $21.90M derived: sum of 3 quarters · filed 2018-02-27 | $23.80M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.42M derived: sum of 2 quarters · filed 2018-02-27 | $11.32M derived: sum of 3 quarters · filed 2018-02-27 | $26.10M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $8.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $10.62M derived: sum of 2 quarters · filed 2016-11-08 | $25.40M 10-Q · filed 2016-11-08 | $26.13M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $16.68M 10-Q · filed 2016-08-09 | $17.40M derived: sum of 3 quarters · filed 2017-02-28 | $24.16M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $14.78M 10-Q · filed 2016-05-10 | $15.50M derived: sum of 2 quarters · filed 2017-02-28 | $22.26M derived: sum of 3 quarters · filed 2017-02-28 | $23.45M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $7.48M derived: sum of 2 quarters · filed 2017-02-28 | $8.67M derived: sum of 3 quarters · filed 2017-02-28 | $18.03M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.94M derived: sum of 2 quarters · filed 2015-11-09 | $17.31M 10-Q · filed 2015-11-09 | $17.59M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $10.55M 10-Q · filed 2015-08-05 | $10.84M derived: sum of 3 quarters · filed 2016-02-23 | $14.54M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $9.36M 10-Q · filed 2015-05-07 | $9.65M derived: sum of 2 quarters · filed 2016-02-23 | $13.36M derived: sum of 3 quarters · filed 2016-02-23 | $13.53M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $3.99M derived: sum of 2 quarters · filed 2016-02-23 | $4.16M derived: sum of 3 quarters · filed 2016-02-23 | $5.59M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $3.88M derived: sum of 2 quarters · filed 2014-11-04 | $5.30M 10-Q · filed 2014-11-04 | $5.30M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $1.60M 10-Q · filed 2014-08-05 | $1.60M derived: sum of 3 quarters · filed 2015-02-24 | $1.60M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $1.43M 10-Q · filed 2014-05-08 | $1.43M derived: sum of 2 quarters · filed 2015-02-24 | $1.43M derived: sum of 3 quarters · filed 2015-02-24 | $1.43M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $25.30M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $25.30M 10-Q · filed 2013-11-05 | $25.30M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $25.30M 10-Q · filed 2013-08-06 | $25.30M derived: sum of 3 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $25.30M 10-Q · filed 2013-05-07 | $25.30M derived: sum of 2 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-09 | |||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |